Abnormal Echocardiography 7Days after Stem Cell Transplantation May Be an Early Indicator of Thrombotic Microangiopathy

Biology of Blood and Marrow Transplantation

Volumn 21, Issue 1, 2015, Pages 113-118

  Dandoy, Christopher E ^a   Davies, Stella M ^a   Hirsch, Russel ^a   Chima, Ranjit S ^a   Paff, Zachary ^a   Cash, Michelle ^a   Ryan, Thomas D ^a   Lane, Adam ^a   El Bietar, Javier ^a   Myers, Kasiani C ^a   Jodele, Sonata ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Echocardiography; Hematopoietic stem cell transplantation; Left ventricle depression; Pericardial effusion; Pulmonary hypertension; Thrombotic microangiopathy

Indexed keywords

ARTICLE; BLOOD VESSEL INJURY; CHILD; CONTROLLED STUDY; ECG ABNORMALITY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE PRESSURE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERICARDIAL EFFUSION; SURVIVAL; THROMBOTIC THROMBOCYTOPENIC PURPURA; ACUTE DISEASE; ADVERSE EFFECTS; ALLOTRANSPLANTATION; CHRONIC DISEASE; CLINICAL TRIAL; DONOR; ECHOGRAPHY; GRAFT VERSUS HOST REACTION; HEART RIGHT VENTRICLE FUNCTION; HEMATOLOGIC NEOPLASMS; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LUNG; MORTALITY; PATHOLOGY; PRESCHOOL CHILD; PROSPECTIVE STUDY; THROMBOTIC MICROANGIOPATHIES; TREATMENT OUTCOME; VASCULARIZATION;

ANTINEOPLASTIC AGENT;

ACUTE DISEASE; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LUNG; MALE; PERICARDIAL EFFUSION; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THROMBOTIC MICROANGIOPATHIES; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84927135808     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.09.028     Document Type: Article

References (38)

1. Oeffinger K.C., Mertens A.C., Sklar C.A., et al. Chronic health conditions in adult survivors of childhood cancer. NEngl J Med 2006, 355:1572-1582.
2. Bodson L., Vieillard-Baron A. Cardiac tamponade. Curr Opin Crit Care 2011, 17:416-424.
3. Jung H.-O. Pericardial effusion and pericardiocentesis: role of echocardiography. Kor Circ J 2012, 42:725-734.
4. Maisch B., Seferović P.M., Ristić A.D., et al. Guidelines on the Diagnosis and Management of Pericardial Diseases Executive Summary: The Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2004, 25:587-610.
5. Roy C.L., Minor M.A., Brookhart M., Choudhry N.K. Does this patient with a pericardial effusion have cardiac tamponade?. JAMA 2007, 297:1810-1818.
6. Sagristà-Sauleda J., Soler-Soler J. Diagnosis and management of pericardial effusion. World J Cardiol 2011, 3:135-143.
7. Murdych T. Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997. Bone Marrow Transplant 2001, 28:283-287.
8. Aldoss O., Gruenstein D.H., Bass J.L., et al. Pericardial effusion after pediatric hematopoietic cell transplant. Pediatr Transplant 2013, 17:294-299.
9. Lerner D., Dandoy C.E., Hirsch R., et al. Pericardial effusion in pediatric SCT recipients with thrombotic microangiopathy. Bone Marrow Transplant 2014, 49:862-863.
10. Fujimaki K., Maruta A., Yoshida M., et al. Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction. Bone Marrow Transplant 2001, 27:307-310.
11. Kantor P.F., Lougheed J., Dancea A., et al. Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines. Can J Cardiol 2013, 29:1535-1552.
12. Gottdiener J.S., Appelbaum F.R., Ferrans V.J., et al. Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Intern Med 1981, 141:758-763.
13. Humbert M., Gerry Coghlan J., Khanna D. Early detection and management of pulmonary arterial hypertension. Eur Respir Rev 2012, 21:306-312.
14. Galie N., Hoeper M.M., Humbert M., et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009, 30:2493-2537.
15. Roofthooft M.T., Hillege H.L., ten Harkel A.D., et al. Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005. Circulation 2011, 124:1755-1764.
16. Humbert M., Sitbon O., Chaouat A., et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 2010, 122:156-163.
17. Dandoy C.E., Hirsch R., Chima R., et al. Pulmonary hypertension after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2013, 19:1546-1556.
18. Soubani A.O., Hassoun P.M. Pulmonary complications of bone marrow transplantation. Chest 1996, 109:1066-1077.
19. Jodele S., Hirsch R., Laskin B., et al. Pulmonary arterial hypertension in pediatric patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy. Biol Blood Marrow Transplant 2013, 19:202-207.
20. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974, 18:295-304.
21. Myers K.C., Lawrence J., Marsh R.A., et al. High-dose methylprednisolone for veno-occlusive disease of the liver in pediatric hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant 2013, 19:500-503.
22. Smith A.R., Majhail N.S., MacMillan M.L., et al. Hematopoietic cell transplantation comorbidity index predicts transplantation outcomes in pediatric patients. Blood 2011, 117:2728-2734.
23. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004, 114:555-576.
24. Cho B.S., Yahng S.A., Lee S.E., et al. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. Transplantation 2010, 90:918-926.
25. Laskin B.L., Goebel J., Davies S.M., Jodele S. Small vessels, big trouble inthe kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood 2011, 118:1452-1462.
26. Ho V.T., Cutler C., Carter S., et al. Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005, 11:571-575.
27. Ruutu T., Barosi G., Benjamin R.J., et al. Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica 2007, 92:95-100.
28. Kirkpatrick E.C. Echocardiography in pediatric pulmonary hypertension. Paediatr Respir Rev 2013, 14:157-164.
29. Forfia P.R., Vachiéry J.-L. Echocardiography in pulmonary arterial hypertension. Am J Cardiol 2012, 110:S16-S24.
30. Bossone E., D'Andrea A., D'Alto M., et al. Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis. JAm Soc Echocardiogr 2013, 26:1-14.
31. Taleb M., Khuder S., Tinkel J., Khouri S.J. The diagnostic accuracy of Doppler echocardiography in assessment of pulmonary artery systolic pressure: a meta-analysis. Echocardiography 2013, 30:258-265.
32. Haddad F., Guihaire J., Skhiri M., et al. Septal curvature is marker of hemodynamic, anatomical, and electromechanical ventricular interdependence in patients with pulmonary arterial hypertension. Echocardiography 2014, 31:699-707.
33. Parent F., Bachir D., Inamo J., et al. Ahemodynamic study of pulmonary hypertension in sickle cell disease. NEngl J Med 2011, 365:44-53.
34. Sparano D.M., Ward R.P. Pericarditis and pericardial effusion: management update. Curr Treat Options Cardiovasc Med 2011, 13:543-555.
35. Gray R. Aclass of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988, 16:1141-1154.
36. Team R.D.C. R: A language and environment for statistical computing 2006, R Foundation for Statistical Computing, Vienna, Austria.
37. Scrucca L., Santucci A., Aversa F. Competing risk analysis using R: aneasy guide for clinicians. Bone Marrow Transplant 2007, 40:381-387.
38. Jodele S., Davies S., Lane A., et al. Refined diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a prospective study in children and young adults. Blood 2014, 124:645-653.